| pubmed-article:15896623 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15896623 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:15896623 | lifeskim:mentions | umls-concept:C0032790 | lld:lifeskim |
| pubmed-article:15896623 | lifeskim:mentions | umls-concept:C0085533 | lld:lifeskim |
| pubmed-article:15896623 | lifeskim:mentions | umls-concept:C0441766 | lld:lifeskim |
| pubmed-article:15896623 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15896623 | pubmed:dateCreated | 2005-5-17 | lld:pubmed |
| pubmed-article:15896623 | pubmed:abstractText | Surgery constitutes the mainstay of treatment in stage I non-small cell lung cancer (NSCLC). However, a significant fraction of patients after surgical resection die mainly due to systemic relapse. Nonetheless, the best adjuvant treatment to improve survival and decrease relapse rate remains as an ever controversial issue. Therefore, we conducted a randomized trial to determine whether postoperative adjuvant chemotherapy is beneficial in prolonging survival and decreasing recurrence in patients with completely resected stage I NSCLC. | lld:pubmed |
| pubmed-article:15896623 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15896623 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15896623 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15896623 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15896623 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15896623 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15896623 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15896623 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15896623 | pubmed:issn | 1010-7940 | lld:pubmed |
| pubmed-article:15896623 | pubmed:author | pubmed-author:ShimYoung... | lld:pubmed |
| pubmed-article:15896623 | pubmed:author | pubmed-author:ParkJong HoJH | lld:pubmed |
| pubmed-article:15896623 | pubmed:author | pubmed-author:LeeChoon-Taek... | lld:pubmed |
| pubmed-article:15896623 | pubmed:author | pubmed-author:BaekHee... | lld:pubmed |
| pubmed-article:15896623 | pubmed:author | pubmed-author:ZoJae IllJI | lld:pubmed |
| pubmed-article:15896623 | pubmed:author | pubmed-author:LeeHae WonHW | lld:pubmed |
| pubmed-article:15896623 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15896623 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:15896623 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15896623 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15896623 | pubmed:pagination | 1086-91 | lld:pubmed |
| pubmed-article:15896623 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:meshHeading | pubmed-meshheading:15896623... | lld:pubmed |
| pubmed-article:15896623 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15896623 | pubmed:articleTitle | Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer. | lld:pubmed |
| pubmed-article:15896623 | pubmed:affiliation | Department of Thoracic Surgery, Korea Cancer Center Hospital, Nowon-Ku Gongneung-Dong 215-4, Seoul 139-706, South Korea. jhpark@kcch.re.kr | lld:pubmed |
| pubmed-article:15896623 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15896623 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15896623 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15896623 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15896623 | lld:pubmed |
